NCT02194738 2026-03-18
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
Clinical Trials
19 trialsNCT02658279 2026-03-03
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT07343596 2026-03-03
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
University of Wisconsin, Madison
Phase NA Recruiting
NCT07436390 2026-03-02
MAK
Institute of Oncology Ljubljana
Phase NA Completed
NCT07422779 2026-02-20
MAK
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT05047094 2025-12-02
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04924374 2024-09-26
Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Phase NA Completed
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT03769129 2024-06-25
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT05368207 2024-03-13
Pemb-HT
University Health Network, Toronto
Phase NA Active not recruiting
NCT05745233 2023-08-24
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
China Medical University Hospital
Phase NA Enrolling by invitation
NCT06000358 2023-08-21
LUCACRIMUNO
Lithuanian University of Health Sciences
Phase NA Recruiting
NCT04793815 2023-06-29
Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Completed
NCT04801966 2023-05-10
TAILOR
Peter MacCallum Cancer Centre, Australia
Phase NA Terminated
NCT05352165 2022-04-28
The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer
Shanghai Minimally Invasive Surgery Center
Phase NA Unknown
NCT05339581 2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA Unknown
NCT05233358 2022-02-10
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
The Central Hospital of Lishui City
Phase NA Unknown
NCT02489357 2021-11-12
Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT04393883 2020-11-30
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown